Legend Biotech (LEGN) Other Gross PP&E Adjustments (2019 - 2025)

Legend Biotech has reported Other Gross PP&E Adjustments for 7 years, with the latest figure at -$285.2 million in Q4 2025.

• For the quarter ending Q4 2025, Other Gross PP&E Adjustments fell 179.88% year-over-year to -$285.2 million; the trailing twelve-month figure through Dec 2025 stood at -$285.2 million (down 179.88% YoY), and the FY2025 full-year result was -$285.2 million, down 179.88% from the prior year.
• Other Gross PP&E Adjustments for Q4 2025 stood at -$285.2 million, down from -$142.3 million in the prior quarter.
• The five-year high for Other Gross PP&E Adjustments was -$7547.0 in Q1 2021, with the low at -$285.2 million in Q4 2025.
• Historically, Other Gross PP&E Adjustments has averaged -$84.5 million across 5 years, with a median of -$80.3 million in 2023.
• Annual changes were most pronounced in 2021 — Other Gross PP&E Adjustments gained 8.08% — and 2022, when it tumbled 526877.61%.
• Legend Biotech's Other Gross PP&E Adjustments stood at -$38.3 million in 2021, then sank by 45.21% to -$55.6 million in 2022, then tumbled by 44.81% to -$80.5 million in 2023, then fell by 26.58% to -$101.9 million in 2024, then tumbled by 179.88% to -$285.2 million in 2025.
• The last three Other Gross PP&E Adjustments figures came in at -$285.2 million (Q4 2025), -$142.3 million (Q3 2025), and -$127.2 million (Q2 2025), per Business Quant data.